ACBNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends March 31
AURORA CANNABIS INC
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 40-F on Jun 11, 2026
$3.96−0.03 (-0.75%)
Close on Oct 19, 2026
AURORA CANNABIS INC revenue by segment
By business segment
| Revenue | FY2026 | FY2025 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Cannabis Operating Segment | – | C$288.91M | – | – | – | – | – | – | – |
| Plant Propagation | – | C$54.38M | – | – | – | – | – | – | – |
By product or service
By region
| Revenue | FY2026 | FY2025 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Canada | C$144.07M | C$151.90M | – | C$211.07M | C$252.86M | C$230.28M | – | 44.9% | -5.2% |
| Europe | C$131.84M | C$83.35M | – | – | – | – | – | 41.1% | +58.2% |
| Australia | C$39.04M | C$51.19M | – | – | – | – | – | 12.2% | -23.7% |
| New Zealand | C$5.65M | C$2.47M | – | – | – | – | – | 1.8% | +128.6% |
| EU | – | – | – | C$29.98M | C$14.61M | C$11.79M | – | – | – |
| Other | – | C$0 | – | C$4.20M | C$1.23M | C$3.47M | – | – | – |
| EU | – | C$83.35M | – | – | – | – | – | – | – |
| Canada | – | C$170.46M | – | – | – | – | – | – | – |
| United States | – | C$35.82M | – | – | – | – | – | – | – |
From the segment and revenue-disaggregation notes of Aurora Cannabis's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.